Table 2.
Differences according to age group.
| <18 years | >18 years | p * | |||
|---|---|---|---|---|---|
| 20 | 41 | ||||
| n | % | n | % | ||
| Gender | |||||
| Female | 14 | 70 | 21 | 51 | 0.7 |
| Male | 6 | 30 | 20 | 49 | |
| Time since symptoms (days) | 24.5 | 10–43 | 30 | 23–42 | 0.6** |
| Time since RCP positive (days) | 23 | 15–37 | 28 | 20–38 | 0.7** |
| Symptoms (weeks) | 1 | 1–3 | 1 | 1–3 | 0.9** |
| IgG SARS-CoV-2 (units) | 0.9 | 0.2–1.87 | 0.55 | 0.02–2.8 | 0.8 |
| Hospitalisation | 12 | 60 | 13 | 32 | 0.02 |
| Endotracheal intubation | 3 | 15 | 0 | 0 | – |
| Influenza vaccine | 3 | 15 | 9 | 22 | 0.7 |
| Commorbilities | 16 | 80% | 17 | 41% | 0.03 |
| SAH | 3 | 15 | 10 | 24 | 0.1 |
| DM | 1 | 5 | 3 | 7 | 0.9 |
| Obesity | 4 | 20 | 4 | 10 | 0.3 |
| Cáncer | 8 | 40 | 0 | 0 | – |
*
x2 test,
**
U Mann–Whitney.
DM, Diabetes Mellitus; SAH, Systemic Arterial Hypertension. Bold values indicate statistical significance.